PLRX insider trading

NasdaqGS Healthcare

PLIANT THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
235
Last 90 days
40
Buys / sells
0% / 44%
Market cap
$72.44M

About PLIANT THERAPEUTICS, INC.

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Company website: pliantrx.com

PLRX insider activity at a glance

FilingIQ has scored 235 insider transactions for PLRX since Apr 30, 2020. The most recent filing in our index is dated Apr 17, 2026.

Across the full history, 0 open-market purchases and 103 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PLRX insider trades is 64.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PLRX trades on FilingIQ Raw filings on SEC EDGAR

Latest PLRX Form 4 filings

Coulie Bernard
S Jan 17, 2025
Coulie Bernard
S Jul 17, 2023
Cummings Keith Lamont
S Jul 17, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098
UNITED THERAPEUTICS Corp
APLS 279
Apellis Pharmaceuticals, Inc.
KMDA 218
KAMADA LTD
BMY 185
BRISTOL MYERS SQUIBB CO
ADPT 184
Adaptive Biotechnologies Corp
GH 169
Guardant Health, Inc.
ISRG 166
INTUITIVE SURGICAL INC
VTRS 165
Viatris Inc

13F funds holding PLRX

VR Adviser, LLC
$22.56M · 3.5% of AUM
Casdin Capital, LLC
$10.75M · 0.8% of AUM

Frequently asked

How many insider trades does FilingIQ track for PLRX?
FilingIQ tracks 235 Form 4 insider transactions for PLRX (PLIANT THERAPEUTICS, INC.), covering filings from Apr 30, 2020 onwards. 40 of those were filed in the last 90 days.
Are PLRX insiders net buyers or net sellers?
Across the full Form 4 history for PLRX, 0 transactions (0%) were open-market purchases and 103 (44%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PLRX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PLRX in?
PLIANT THERAPEUTICS, INC. (PLRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $72.44M.

Methodology & sources

Every PLRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.